ALB ALBEMARLE CORP
Plastic Materials, Synth Resins & Nonvulcan Elastomers · NYSE · SEC CIK 915913 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY24.4%
TTM net income YoY3,321.9%
TTM EPS YoY361.0%
Revenue 3-yr CAGR-14.6%
Net income 3-yr CAGR-41.0%
Margins
Gross margin25.8%
Operating margin10.0%
Net margin11.1%
FCF margin23.5%
EBITDA margin20.5%
Returns
ROE6.6%
ROA4.1%
ROIC (approx.)2.8%
Asset turnover0.37x
Leverage & solvency
Liabilities / assets32.7%
Debt / equity0.18x
Current ratio2.34x
Interest coverage4.13x
Cash quality & payout
Operating cash flow / net income2.71x
Accruals ratio-7.0%
Payout ratio28.0%
Capex / revenue6.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $5.14B | $5.38B |
| Cost of revenue | $4.47B | $5.31B |
| Gross profit | $668.72M | $62.54M |
| R&D expense | $51.40M | $86.72M |
| SG&A expense | $550.04M | $618.05M |
| Operating income | -$367.08M | -$1.78B |
| Interest expense | $207.65M | $165.62M |
| Pretax income | -$552.07M | -$1.76B |
| Income tax | $156.88M | $87.08M |
| Net income | -$510.63M | -$1.18B |
| EBITDA | $291.59M | -$1.19B |
| EPS (basic) | -5.76 | -11.20 |
| EPS (diluted) | -5.76 | -11.20 |
| Dividends declared per share | 1.62 | 1.61 |
| Weighted avg. shares (diluted) | 117.66M | 117.52M |
| Balance sheet | ||
| Cash & equivalents | $1.62B | $1.19B |
| Receivables | $593.50M | $742.20M |
| Inventory | $1.18B | $1.50B |
| Current assets | $4.01B | $3.84B |
| PP&E, net | $8.61B | $9.33B |
| Goodwill | $1.50B | $1.58B |
| Intangibles | $214.23M | $230.75M |
| Total assets | $16.37B | $16.61B |
| Current liabilities | $1.80B | $1.97B |
| Short-term debt | $74.08M | $398.02M |
| Long-term debt | $3.12B | $3.12B |
| Total debt | $3.19B | $3.52B |
| Total liabilities | $6.59B | $6.41B |
| Shareholders' equity | $9.53B | $9.96B |
| Net debt | $1.58B | $2.32B |
| Shares outstanding | 117.72M | 117.56M |
| Cash flow statement | ||
| Operating cash flow | $1.28B | $687.88M |
| Capital expenditure | $589.80M | $1.68B |
| Free cash flow | $692.47M | -$992.65M |
| Investing cash flow | -$146.01M | -$1.58B |
| Financing cash flow | -$834.19M | $1.24B |
| Depreciation & amortization | $658.68M | $588.64M |
| Stock-based compensation | $40.27M | $32.14M |
| Dividends paid | $190.53M | $188.53M |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.